# Intraoperative Lidocaine Infusion as a Sole Analgesic Versus Morphine in Laparoscopic Gastric Bypass Surgery

> **NCT05150756** · EARLY_PHASE1 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Lidocaine Hydrochloride 2% Intravenous Solution [XYLOCAINE]
- **DRUG:** morphine sulphate (10mg/ ml ampoule)

## Key facts

- **NCT ID:** NCT05150756
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-07-28
- **Final completion:** 2022-09-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05150756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05150756, "Intraoperative Lidocaine Infusion as a Sole Analgesic Versus Morphine in Laparoscopic Gastric Bypass Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05150756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*